LANA

Lana Medical Co.

9587StocksTadawulHealthcare

Financials

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	156.06M	131.76M	159.84M	115.20M	—
Market Cap Growth	-1.9%	-17.6%	+38.8%	—	—
Enterprise Value	180.60M	140.81M	161.28M	120.12M	—
Last Close Price	2.89	2.44	2.96	2.13	—
Valuation Multiples
PE Ratio	57.88	48.87	12.83	—	—
PS Ratio	1.69	1.43	1.90	2.37	—
PB Ratio	2.40	2.02	2.62	2.36	—
P/TBV Ratio	2.40	2.03	2.63	2.37	—
P/OCF Ratio	—	—	406.51	112.52	—
EV/Sales Ratio	1.96	1.53	1.92	2.47	—
EV/EBITDA Ratio	16.57	13.71	14.43	107.83	—
EV/EBIT Ratio	34.75	23.67	19.03	—	—
Leverage & Capital
Debt / Equity Ratio	0.45	0.45	0.25	0.23	0.16
Debt / EBITDA Ratio	2.49	2.49	1.29	7.11	0.94
Debt / FCF Ratio	—	—	—	—	15.15
Net Debt / Equity Ratio	0.38	0.38	0.15	-0.15	0.09
Net Debt / EBITDA Ratio	2.39	2.39	0.81	-6.67	0.56
Net Debt / FCF Ratio	-2.37	-2.37	-2.43	3.06	8.50
Efficiency & Liquidity
Asset Turnover	0.79	0.79	0.94	0.70	0.68
Inventory Turnover	9.09	9.09	15.44	8.34	5.37
Quick Ratio	1.11	1.11	1.47	2.38	3.34
Current Ratio	1.58	1.58	1.87	3.03	4.16
Returns & Yields
Return on Equity (ROE)	+4.3%	+4.3%	+22.7%	-4.0%	+12.3%
Return on Assets (ROA)	+3.2%	+3.2%	+5.9%	-0.3%	+6.8%
Return on Invested Capital (ROIC)	+4.8%	+5.4%	+13.9%	-0.8%	+11.0%
Return on Capital Employed (ROCE)	+7.5%	+7.5%	+11.8%	-0.6%	+12.4%
Earnings Yield	+1.7%	+2.0%	+7.8%	-1.7%	—
FCF Yield	-6.6%	-7.9%	-2.3%	-2.1%	—
Buyback Yield / Dilution	—	—	-18.4%	-1.4%	-37.1%

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	156.06M	131.76M	159.84M	115.20M	—
Market Cap Growth	-1.9%	-17.6%	+38.8%	—	—
Enterprise Value	180.60M	140.81M	161.28M	120.12M	—
Last Close Price	2.89	2.44	2.96	2.13	—
Valuation Multiples
PE Ratio	57.88	48.87	12.83	—	—
PS Ratio	1.69	1.43	1.90	2.37	—
PB Ratio	2.40	2.02	2.62	2.36	—
P/TBV Ratio	2.40	2.03	2.63	2.37	—
P/OCF Ratio	—	—	406.51	112.52	—
EV/Sales Ratio	1.96	1.53	1.92	2.47	—
EV/EBITDA Ratio	16.57	13.71	14.43	107.83	—
EV/EBIT Ratio	34.75	23.67	19.03	—	—
Leverage & Capital
Debt / Equity Ratio	0.45	0.45	0.25	0.23	0.16
Debt / EBITDA Ratio	2.49	2.49	1.29	7.11	0.94
Debt / FCF Ratio	—	—	—	—	15.15
Net Debt / Equity Ratio	0.38	0.38	0.15	-0.15	0.09
Net Debt / EBITDA Ratio	2.39	2.39	0.81	-6.67	0.56
Net Debt / FCF Ratio	-2.37	-2.37	-2.43	3.06	8.50
Efficiency & Liquidity
Asset Turnover	0.79	0.79	0.94	0.70	0.68
Inventory Turnover	9.09	9.09	15.44	8.34	5.37
Quick Ratio	1.11	1.11	1.47	2.38	3.34
Current Ratio	1.58	1.58	1.87	3.03	4.16
Returns & Yields
Return on Equity (ROE)	+4.3%	+4.3%	+22.7%	-4.0%	+12.3%
Return on Assets (ROA)	+3.2%	+3.2%	+5.9%	-0.3%	+6.8%
Return on Invested Capital (ROIC)	+4.8%	+5.4%	+13.9%	-0.8%	+11.0%
Return on Capital Employed (ROCE)	+7.5%	+7.5%	+11.8%	-0.6%	+12.4%
Earnings Yield	+1.7%	+2.0%	+7.8%	-1.7%	—
FCF Yield	-6.6%	-7.9%	-2.3%	-2.1%	—
Buyback Yield / Dilution	—	—	-18.4%	-1.4%	-37.1%